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DRUG REACTIONS FROM BARBITAL (Veronal)
AND PHENOBARBITAL (Luminal)
ALLAN K. POOLE
Within the last fifteen years barbital and phenobarbital have
achieved a justifiable popularity as sedatives and anticonvulsants.
In spite of widespread use, reports of untoward reactions are not
numerous, and there seems to be a general tendency to regard these
drugs as harmless. A careful survey of the literature shows that
this idea is not entirely correct, and the present purpose is to call
attention to certain reactions which may occur following the use of
barbital and phenobarbital.
Menninger5 gives a very complete review of the 43 cases re-
ported before I928, and emphasing the skin eruptions, adds three
from his own clinic.
It is impossible to state the frequency with which reactions
occur. Prior to I920, when larger doses were in vogue, reactions
appear to have been rather common. With the use of smaller
doses reactions have been less frequent, but have by no means
disappeared. Menninger estimates reactions as occurring in one to
three per cent of the cases. It is significant that most manufacturers
of the drugs advise small doses and their advertising circulars warn
of all the possible reactions. Little attention has been paid to this
advice, and on the contrary when reactions do occur the tendency
is to call them everything except drug reactions.
There are two distinct types of reaction,-a general systemic
reaction with signs of acute poisoning, and skin reactions, with or
without mild systemic disturbance. Menninger further classifies
the skin reactions into the urticarial type, and the toxic type char-
acterized by a diffuse erythematous maculo-papular rash. Occa-
sionally vesicles have been noted with the dermatitis and in the
cases reported by Heuber3 and Haxthausen2 hemorrhagic areas de-
veloped. The duration of the skin rash has varied greatly, rang-
ing from two days to three weeks. Exfoliative dermatitis and
pigmentation of the skin have been reported.
Although most of the severe reactions have occurred after large
doses, Phillips6, Bothe', Jackson4, and Menninger5, all report re-YALE JOURNAL OF BIOLOGY AND MEDICINE
actions in patients receiving i>2 grains per day. The amount re-
quired to produce reactions and the time of their appearance has
varied greatly. Reactions have occurred within 24 hours of the
institution of treatment and as late as 8 i days. Obviously this
wide variation may lead to difficulty in diagnosis. In some cases
it has been possible to resume medication with smaller doses, but
in others, reactions have recurred every time treatment was resumed.
General systemic reactions have been observed but the literature
contains very few references to this phase of the reaction. Stupor,
mental disturbances, speech disorders and paresthesias have been
reported in the true poisoning cases. Febrile reactions were com-
mon in this group.
It is interesting that the cases showing a severe general re-
action had no dermatitis, while the dermatitis group showed a
slight or moderate general reaction, such as fever, sometimes as
high as I04-I05, nausea, vomiting, diarrhea, headache, stomatitis,
pharyngitis, and conjunctivitis. Leucocytosis and eosinophilia were
often striking findings.
The following eleven cases from the New Haven Hospital
are reported; all occurred within the last five years. As far as we
can ascertain the fatal case included in this series is the only one
on record in which an autopsy was performed. These cases may
be divided into two groups, those showing a skin reaction following
therapeutic dosage (4 cases), and those showing a general reaction
(7 cases) either from therapeutic dosage or from a larger amount
taken with suicidal intent.
CASE REPORTS
Case i. The patient was a white boy of 8½Y2 years suffering
from chorea and rheumatic heart disease. He was given Luminal
gr. Y4 q.i.d. Two days later the temperature began to vary from
97.4 to I00.4 . Nine days after the beginning of Luminal therapy
a profuse pink, macular, skin rash was noted over the trunk and ex-
tensor surfaces of the extremities. Over the thighs and knees the
rash was purple and urticarial in type, but was not influenced by
adrenalin. Luminal was suspected as the cause and medication
was stopped. Three days later the skin rash had disappeared and
the temperature was normal. Because of the uncertainty concern-
ing the role of Luminal, the drug was again given, gr. Y4 q.i.d.
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for four doses. The following day the rash was again present
and the temperature was elevated. Three days later all signs and
symptoms had disappeared.
Case 2. The patient was a woman of 4I years presenting the
signs and symptoms of chronic nephritis. Because of insomnia she
was given i>2 gr. of Luminal on alternate days for a total of three
doses. Nine days after the first dose and four days after the last
dose, a profuse maculopapular rash was noted over the trunk and
extremities. The rash was confluent for the most part and itching
was pronounced. There was hyperemia of the conjunctivx and
buccal mucosa, with two small red papules on the soft palate.
During the next few days the temperature rose to IO3.4°. Leucocy-
tosis varied between 22,000 and 25,000 with one to two per cent
eosinophilia. The rash gradually became definitely urticarial. The
erythema changed to a copper color, and the papules on the soft
palate became ulcerated. Desquamation of the skin developed.
One week after the rash appeared the patient went into coma,
and pulmonary edema was noted. Death occurred two days later.
Autopsy: In addition to the findings of nephritis, several points
were of interest. There was desquamation of the skin. The bronchi
were congested and the mucosal surface appeared granular. Mi-
croscopic sections showed desquamation of the mucosa, edema,
infiltration with leucocytes, and capillary engorgement. The
alveoli were filled with fluid. The kidney pelves and ureters
showed a process similar to that in the bronchi, and the lymph
glands showed endothelial hyperplasia.
Case 3. The patient was a mentally deficient white girl of IS
years who was given small doses of Fowler's solution and Luminal
gr. 34 b.i.d. Twelve days after beginning this medication a skin
rash developed. At this time the face was flushed and swollen,
particularly about the nose and lips. The conjunctiva and throat
were quite injected. An extensive, pink, papular, definitely urticar-
ial rash covered almost the entire body. On the inner aspect of
the thighs the rash was confluent. General glandular enlargement
was found. There was slight general malaise. The W. B. C.
was 5,200, with 80 per cent polymorphonuclears and 2 per cent
eosinophiles. The following day the W. B. C. was 2,600;
polymorphonuclears 30 per cent and eosinophiles 22 per cent.YALE JOURNAL OF BIOLOGY AND MEDICINE
After four days the edema of the skin had disappeared, the rash
was purple in color and less intense, and pigmentation was evi-
dent. Ten days later all symptoms had disappeared and the
blood count had returned to normal, but the brownish pigmen-
tation of the skin persisted. Because of the possibility of Fowler's
solution as a cause of the dermatitis, an intradermal skin test was
made with a solution of Luminal.
A two per cent solution of sodium luminal (hypodermic tablet)
was used for the skin test. Approximately 0.02 cc. was injected
intradermally on the flexor surface of the forearm, and a similar
amount of physiological salt solution was injected in the other arm
as a control. Two minutes after injection an urticarial wheal
with pseudopod formation developed at the point of the injection
of Luminal. This increased rapidly in size and edema developed.
After thirty minutes the area of edema measured 5 by 8 cm. The
edema remained unchanged for two hours more and then gradu-
ally disappeared. The control test was negative.
Case 4. The patient was a white woman of 45 years who
began taking Luminal gr. Y4 q.i.d. for the relief of pain caused by
cystitis. One week later she noticed tingling and numbness of the
third and fourth fingers of each hand. This was followed by the
sensations of pain and burning of the skin of both hands. Luminal
was continued at this dosage for five months and the symptoms
persisted. The dose was then increased to six grains per day.
After six weeks on this dosage a skin rash developed and eleven
days later she was admitted to the hospital. At that time there
was a diffuse maculopapular eruption over the entire body, most
marked over the hands and inner aspect of the thighs. The W.
B. C. was 5,500, with polymorphonuclears 6o per cent and eosino-
philes 4 per cent. The drug was immediately discontinued and
improvement began promptly. One week later all signs and
symptoms had disappeared.
Case S. Ihe patient was a white male of 27 years who was
given Luminal for the relief of pain following dental extraction.
As the amount prescribed did not relieve the pain, he increased
the amount, taking "2 boxes" in three days. On admission he
showed marked lethargy, disorientation, loss of memory, and lateral
nystagmus. The W. B. C. was 9,oo0, with polymorphonuclears
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64 per cent and eosinophiles 2 per cent. With no medication'other
than forced fluids and rest in bed, the patient was well three
days later.
Case 6. The patient, a white woman of 48 years, who had
been accustomed to taking daily I½ gr. of Luminal for over a
year, took twelve iY2 gr. Luminal tablets with suicidal intent.
When found several hours later she was in coma, the face was
flushed and her respirations were IS per minute. The W. B. C.
was i6,ooo, with polymorphonuclears 70 per cent. She responded
to symptomatic treatment and five days later had completely re-
covered.
Case 7. A white woman of 28 years was admitted to the
hospital four hours after taking ten IY2 gr. Luminal tablets.
Examination showed marked cyanosis, and rapid, jerky, and shallow
respirations, with a rate of 30 per minute. She was deeply coma-
tose. The W. B.} C. was 8,ooo, with polymorphonuclears 79
per cent. She responded to symptomatic treatment and recovered
in three days.
Case 8. The patient, a woman of 48 years, had been given
Veronal io gr. b.i.d. for the relief of abdominal pain. As this
did not relieve her, she increased the dose, taking IIO gr. within
24 hours. She was admitted to the hospital after she had been
in coma for four days. At the time of admission she could be
aroused from coma, but was quite irrational. The knee jerks and
ankle jerks were absent. The patient showed a febrile reaction
but no leucocytosis for four days more, and then gradually im-
proved. Two weeks after admission the tendon reflexes were
normal and the patient was well.
Case 9. Because of insomnia, the patient, a boy of I9 years,
took 40 grains of Veronal. He was found in a stuporous con-
dition the following morning. When aroused he complained of
dizziness and double vision. Speech was thick and he had diffi-
culty in finding words. On admission, two days later, he was
very drowsy. The pupils were sluggish, there was drooping of
the eyelids, marked lateral and slight vertical nystagmus, ataxia,
and the abdominal and plantar reflexes were absent. The W. B.
C. was 3,600, with polymorphonuclears 79 per cent. Four days
later the patient had entirely recovered.YALE JOURNAL OF BIOLOGY AND MEDICINE
Case io. A woman of 73 years was admitted because of
mental confusion and inability to walk. The history revealed that
she had been taking "large doses" of Veronal nightly for several
years. Examination showed dysarthria, mental confusion, lateral
nystagmus and ataxia. The blood count was normal. No med-
ication was given. Five days after admission she was clear men-
tally and at the end of ten days was able to walk.
Case ii. The patient was a woman of 3I years, who had
taken i2 Veronal tablets with suicidal intent. She was found two
hours later and brought to the hospital. At this time she was in
deep coma and the respirations were I2 per minute. The W. B.
C. was 6,ooo, with polymorphonuclears 54 per cent and eosino-
philes 2 per cent. Gastric lavage was done and the patient was
given stimulants. Two days later she had recovered entirely.
These cases serve to illustrate the two types of reaction to
Luminal and Veronal.
It is of interest that the cases showing a dermatitis had re-
ceived, as a rule, much smaller doses than had those with symp-
toms of poisoning. Conversely, none of the poisoning cases showed
skin reactions. The blood counts in these cases are similar to
those previously reported. The most marked variations in the
white blood cell counts and in the eosinophilia occurred in the
dermatitis group.
The one fatal case is of importance not only because of the
outcome but because it shows that the exfoliative reaction is not
confined to the skin. In this case it extended to involve the
bronchi, kidney pelves and ureters. This suggests that the mech-
anism of death in exfoliative dermatitis is bronchial obstruction,
and not bronchopneumonia.
In many cases of drug rashes the causative agent is not always
known, due to the fact that several drugs may have been admin-
istered. In Case i of this series the diagnosis was established by
the appearance of the rash when the drug was again administered.
In Case 3 the positive skin test appears to be satisfactory proof of
the causative agent. It is, therefore, suggested that a skin test
with the drug be used then it is suspected as the cause.
The mechanism of the reaction in the poisoning cases is re-
latively clear. In the dermatitis cases, the relative infrequency,
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the type of skin rash, the blood picture, and the reaction to in-
tradermal skin tests suggest a drug idiosyncrasy, allergic in nature.
SUMMARY
i. Attention is called to the possible untoward reactions from
Luminal and Veronal.
2. Eleven cases are reported, four with dermatitis and seven
with general systemic reactions.
3. A fatal case, with autopsy findings, is reported. An ex-
planation is offered of the mechanism of death in cases of ex-
foliative dermatitis.
4. Intradermal skin tests are suggested as a diagnostic method
in these cases.
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